• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,126.55 26.08
( 0.03%)
Global Indices
Nasdaq
51,823.54 -118.08
(-0.23%)
Dow Jones
7,358.68 -19.81
(-0.27%)
Hang Seng
69,065.93 -3,300.41
(-4.56%)
Nikkei 225
10,515.14 -14.75
(-0.14%)
Forex
USD-INR
94.41 -0.14
(-0.15%)
EUR-INR
107.28 -0.07
(-0.07%)
GBP-INR
124.48 -0.08
(-0.06%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Sun Pharmaceutical Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
524715
INE044A01036
93.2373503
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
SUNPHARMA
148.85
446792.16
EPS(TTM)
Face Value()
Div & Yield %
12.51
1
0.86
 

Hindustan Unilever consolidated net profit rises 21.43% in the March 2026 quarter
Apr 30,2026
Net profit of Hindustan Unilever rose 21.43% to Rs 2992.00 crore in the quarter ended March 2026 as against Rs 2464.00 crore during the previous quarter ended March 2025. Sales rose 8.15% to Rs 16207.00 crore in the quarter ended March 2026 as against Rs 14985.00 crore during the previous quarter ended March 2025.

For the full year,net profit rose 41.23% to Rs 15040.00 crore in the year ended March 2026 as against Rs 10649.00 crore during the previous year ended March 2025. Sales rose 5.27% to Rs 63763.00 crore in the year ended March 2026 as against Rs 60573.00 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales16207.0014985.00 8 63763.0060573.00 5
OPM %23.6724.14 -23.5924.26 -
PBDT4025.003850.00 5 15380.0015334.00 0
PBT3677.003532.00 4 14047.0014081.00 0
NP2992.002464.00 21 15040.0010649.00 41